Cigna Group (CI)

The Cigna Group is a global health company, incorporated in Delaware in 1981 (renamed from Cigna Corporation in February 2023), serving over 164 million customer relationships across more than 30 markets with approximately 72,500 employees. The company operates through two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services provides pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery/management solutions, reporting $153.5 billion in adjusted revenues and $6.4 billion in pre-tax adjusted income from operations in 2023; key brands include Express Scripts (PBM and pharmacy), Accredo (specialty pharmacy), CuraScript SD (specialty distribution), eviCore Healthcare (medical benefits management), and MDLIVE (virtual care).

Cigna Healthcare comprises the U.S. Healthcare segment (commercial medical plans, Medicare Advantage, Medicare Supplement, Medicare Part D, and individual health insurance) and International Health segment (health solutions for international markets and globally mobile individuals), formed by merging the former U.S. Commercial and U.S. Government segments in Q4 2023. In January 2024, the company agreed to sell its Medicare Advantage, Medicare Stand-Alone Prescription Drug Plans, Medicare and Other Supplemental Benefits, and CareAllies businesses to Health Care Service Corporation for $3.3 billion, pending regulatory approval. A separate "Other Operations" segment includes corporate-owned life insurance and run-off businesses (variable annuity reinsurance, settlement annuities, and individual life/annuity/retirement benefits), along with exited businesses such as the international life, accident and supplemental benefits operations sold to Chubb in July 2022 and a Türkiye joint venture interest sold in December 2022.

The company emphasizes cross-enterprise leverage between its two platforms to deepen client relationships, cites deep clinical expertise, data analytics, and innovation partnerships as core strengths, and holds over 400 U.S. patents while not being substantially dependent on any single patent.